BetterScholar BetterScholar
10
Role
Title
Level Year L/R
🐬 The hemostatic system.
J. Stassen, J. Arnout, H. Deckmyn
7 2004
7
🐬
🐜 Correlation between Oxidized Low Density Lipoproteins and von Willebrand Factor in Chronic Renal Failure
9 auth. P. Holvoet, J. Donck, Michèle Landeloos, E. Brouwers, K. Luijtens, J. Arnout, ... E. Lesaffre, Y. Vanrenterghem, D. Collen
7 1996
7
🐜
🐬 Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study
R. Demeyere, S. Gillardin, J. Arnout, P. Strengers
7 2010
7
🐬
🐜 Factor VIII Inhibitors in Previously Treated Haemophilia A Patients with a Double Virus-inactivated Plasma Derived Factor VIII Concentrate
8 auth. K. Peerlinck, J. Arnout, M. Giambattista, J. Gilles, R. Laub, M. Jacquemin, ... J. Saint‐Remy, J. Vermylen
7 1997
7
🐜
🦁 The Pathogenesis of the Antiphospholipid Syndrome: a Hypothesis Based on Parallelisms with Heparin-induced Thrombocytopenia
J. Arnout
7 1996
7
🦁
🐬 PROLONGING PROSTACYCLIN PRODUCTION BY NAFAZATROM OR DIPYRIDAMOLE
H. Deckmyn, P. Gresele, J. Arnout, A. Todisco, J. Vermylen
7 1984
7
🐬
🐬 Dipyridamole Inhibits Platelet Aggregation in Whole Blood
P. Gresele, C. Zoja, H. Deckmyn, J. Arnout, J. Vermylen, M. Verstraete
7 1983
7
🐬
🦁 Antiphospholipid Syndrome: Diagnostic Aspects of Lupus Anticoagulants
J. Arnout
7 2001
7
🦁
🐜 Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass.
8 auth. F. Somer, Y. Belleghem, F. Caes, K. FranΓ§ois, H. V. Overbeke, J. Arnout, ... Y. Taeymans, G. Nooten
6 2002
6
🐜
🦁 Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease
J. Arnout, J. Vermylen
6 2003
6
🦁